BIOFRONTERA

biofrontera-logo

Biofrontera AG is a biopharmaceutical company specializing on the development of drugs and medicinal cosmetics for the treatment of skin diseases and the regenerative care of damaged skin. In February 2012 Biofrontera launched the prescription drug Ameluz® for the treatment of actinic keratosis on the German market. In other European countries Ameluz® is marketed through various local representatives. Ameluz® is applied in Photodynamic Therapy requiring a powerful source of red light. For ... this Biofrontera has developed the BF-RhodoLED® lamp, which was CE marked in November 2012. US FDA approval of Ameluz® and activating PDT-lamp BF-RhodoLED® for the treatment of actinic keratoses was granted in May 2016. As a cosmeceutical product Biofrontera markets Belixos® creme for the regenerative care of reddened and inflamed skin. It is Biofrontera’s intention to develop a line of cosmeceutical products for damaged skin under the Belixos brand. The Biofrontera Group consists of the parent company Biofrontera AG and five wholly owned direct subsidiaries - Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, Biofrontera Development GmbH, Biofrontera Neuroscience GmbH and Biofrontera Inc. Biofrontera Inc. has its registered office in Wakefield, MA, USA. All the other companies are based at Hemmelrather Weg 201 in 51377 Leverkusen, Germany. The listed public limited company (AG in German) has a holding function in the group of companies and ensures the necessary financing for the Group. Biofrontera Bioscience GmbH undertakes the research and development tasks for the Group and is the holder of patents and the approval for Ameluz®. Based on a licence agreement with Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, which is also the holder of the approval for BF-RhodoLED®, is responsible for the manufacturing and also the further licensing and marketing of the Biofrontera Group’s approved products. Biofrontera Development GmbH and Biofrontera Neuroscience GmbH were established as additional wholly owned subsidiaries of Biofrontera AG in December 2012. The purpose of both companies is to pursue the further development of pipeline products that are not part of Biofrontera's core business and therefore cannot be sufficiently financed within the framework of normal business development. The product BF-derm1, which is intended for the treatment of severe chronic urticaria, is the responsibility of Biofrontera Development GmbH, while the product BF-1, which is intended for the prophylactic treatment of migraines, is the responsibility of Biofrontera Neuroscience GmbH. By outsourcing the development projects, a structure has been created through which the financing of the further development of these two products can be separated from the normal Group financing. Biofrontera Inc. was established in March 2015 and will be used to conduct business in the USA.

#SimilarOrganizations #People #Website #More

BIOFRONTERA

Industry:
Biopharma Health Care Pharmaceutical

Founded:
1997-01-01

Address:
Leverkusen, Nordrhein-Westfalen, Germany

Country:
Germany

Website Url:
http://www.biofrontera.com

Total Employee:
11+

Status:
Active

Contact:
+490214876320

Email Addresses:
[email protected]

Total Funding:
15 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Microsoft Exchange Online Office 365 Mail GoDaddy DNS ASP.NET IIS


Similar Organizations

antaros-medical-ab-logo

Antaros Medical AB

Antaros Medical is a pharmaceutical company specialized in MRI, PET, Clinical Trials and Studies.

camurus-logo

Camurus

A pharmaceutical company specialising in developing innovative specialty medicines based in Lund

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

immutep-logo

Immutep

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.

mithra-pharmaceuticals-sa-logo

Mithra Pharmaceuticals SA

Mithra Pharmaceuticals SA specializes in the development of women's health care products.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

stago-logo

Stago

Stago is a pharmaceutical company with a strong interest in clinical pathology and in Haemostasis.

stallergenes-greer-logo

Stallergenes Greer

Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the diagnosis and treatment of allergies.

Current Employees Featured

hermann-lubbert_image

Hermann Lubbert
Hermann Lubbert CEO and founder @ Biofrontera
CEO and founder
1998-01-01

ludwig-lutter_image

Ludwig Lutter
Ludwig Lutter Chief Financial Officer @ Biofrontera
Chief Financial Officer
2021-03-01

erica-monaco_image

Erica Monaco
Erica Monaco Chief Executive Officer @ Biofrontera
Chief Executive Officer
2021-10-01

Founder


hermann-lubbert_image

Hermann Lubbert

Stock Details


Company's stock symbol is NASDAQ:BFRA

Official Site Inspections

http://www.biofrontera.com Semrush global rank: 2.69 M Semrush visits lastest month: 6.18 K

  • Host name: static.81.109.47.78.clients.your-server.de
  • IP address: 78.47.109.81
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Biofrontera" on Search Engine